Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix seeks approval for IntraDose in Europe

Nov. 27, 2001

Protein tyrosine kinase inhibitors from AHP exert antitumor activity in vitro

Nov. 26, 2001

Antitumor sulfonamide derivatives reported in recent patent by Sankyo

Nov. 26, 2001

Specific inhibition of MMP-2 binding to alphavbeta3 integrin for inhibiting angiogenesis

Nov. 26, 2001

Design and biological activity of new camptothecin glycoconjugates described by Bayer

Nov. 26, 2001

Inhibitors of certain receptor tyrosine kinases in early development at Celltech

Nov. 23, 2001

PharmaMar's ET-743 filed in E.U. for advanced soft tissue sarcoma

Nov. 23, 2001

Pegylation of rMETase significantly prolongs half-life and biological activity

Nov. 23, 2001

Tarceva enters new phase III trial in combination with gemcitabine and cisplatin

Nov. 23, 2001

Potential development candidates emerging from Panacea's HAAH-targeted oncology program

Nov. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...